U.S. Is Working to Send Doses Abroad by Replacing AstraZeneca Shots With Others

Production problems at an Emergent BioSolutions manufacturing plant are forcing the administration to revise its plan to send AstraZeneca doses overseas.,Production problems at an Emergent BioSolutions manufacturing plant are forcing the administration to revise its plan to send AstraZeneca doses overseas.

Leave a Reply